Optimized Anchor-Modified Peptides Targeting Mutated RAS Are Promising Candidates for Immunotherapy
dc.contributor.author | Baleeiro, RB | en_US |
dc.contributor.author | Dunmall, LSC | en_US |
dc.contributor.author | Liu, P | en_US |
dc.contributor.author | Lu, S | en_US |
dc.contributor.author | Lone, Y | en_US |
dc.contributor.author | Lemoine, NR | en_US |
dc.contributor.author | Wang, Y | en_US |
dc.date.accessioned | 2024-01-09T15:59:34Z | |
dc.date.available | 2022-04-28 | en_US |
dc.date.issued | 2022 | en_US |
dc.identifier.issn | 1664-3224 | en_US |
dc.identifier.other | ARTN 902709 | |
dc.identifier.other | ARTN 902709 | |
dc.identifier.other | ARTN 902709 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/93684 | |
dc.relation.ispartof | FRONTIERS IN IMMUNOLOGY | en_US |
dc.rights | Attribution 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/us/ | * |
dc.subject | RAS | en_US |
dc.subject | neo-antigens | en_US |
dc.subject | cancer immunotherapy | en_US |
dc.subject | cancer vaccine | en_US |
dc.subject | cancer peptides | en_US |
dc.subject | T-cells | en_US |
dc.title | Optimized Anchor-Modified Peptides Targeting Mutated RAS Are Promising Candidates for Immunotherapy | en_US |
dc.type | Article | |
dc.identifier.doi | 10.3389/fimmu.2022.902709 | en_US |
pubs.author-url | https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000812763700001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 13 | en_US |